Ozurdex

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2018
0204020102018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The purpose of this study is to report the efficacy of intravitreal Ozurdex implant in managing recalcitrant diabetic macular… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
2015
2015
The purpose of this study was to investigate the safety and effectiveness of an intravitreally injected dexamethasone-containing… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2014
Highly Cited
2014
PURPOSE To evaluate the safety and efficacy of dexamethasone intravitreal implant (Ozurdex, DEX implant) 0.7 and 0.35 mg in the… (More)
Is this relevant?
2014
2014
PURPOSE To describe the side effects and management after inadvertent injection of a dexamethasone implant (Ozurdex) into the… (More)
Is this relevant?
2014
2014
AIMS This retrospective analysis was aimed at evaluating the effectiveness of treatment of persistent diabetic macular edema with… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
BACKGROUND To evaluate the efficacy and safety of an intravitreal dexamethasone implant (Ozurdex®; Allergan Inc, Irvine, CA, USA… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2013
2013
PurposeTo evaluate the efficacy and safety of a dexamethasone implant (Ozurdex) alone or in combination with bevacizumab… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
CONTEXT Dexamethasone Posterior-Segment Drug Delivery System is a novel, biodegradable, sustained-release drug delivery system… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE To determine the pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone (DEX) intravitreal implant… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
OBJECTIVE To evaluate the safety and efficacy of dexamethasone intravitreal implant (DEX implant; OZURDEX, Allergan, Inc., Irvine… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • table 2
Is this relevant?